Document Detail


FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
MedLine Citation:
PMID:  19104727     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 63-year-old man presented with recent-onset symptoms secondary to third-degree atrio-ventricular block, for which a dual-chamber pacemaker was inserted. Additional investigations resulted in the diagnosis of cardiac sarcoidosis. FDG-PET and MIBI-technetium SPECT were used as follow-up tools for monitoring active granulomatous myocardial infiltration.
Authors:
J P Smedema; L White; A J Klopper
Related Documents :
15272897 - The screening for x-linked emery-dreifuss muscular dystrophy amongst young patients wit...
6192407 - A new atrial lead with improved stability and p-wave detection.
15271027 - Magnetic resonance imaging-based biventricular pacemaker upgrade.
15185907 - Twiddler's syndrome and pectoral stimulation in a patient with dual-site unipolar atria...
21385977 - Emergency cardiac surgery in patients with acute coronary syndromes: a review of the ev...
20674087 - Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assi...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cardiovascular journal of Africa     Volume:  19     ISSN:  1995-1892     ISO Abbreviation:  -     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-12-23     Completed Date:  2009-03-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101313864     Medline TA:  Cardiovasc J Afr     Country:  South Africa    
Other Details:
Languages:  eng     Pagination:  309-10     Citation Subset:  IM    
Affiliation:
Lazaron Heart Clinic, Netcare N1 City Hospital, Goodwood. jansmedema@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atrioventricular Block / etiology,  radionuclide imaging,  therapy*
Cardiomyopathies / complications,  radionuclide imaging*,  therapy
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Immunosuppressive Agents / therapeutic use
Male
Methotrexate / therapeutic use
Middle Aged
Pacemaker, Artificial*
Positron-Emission Tomography*
Radiopharmaceuticals / diagnostic use*
Sarcoidosis / complications,  radionuclide imaging*,  therapy
Steroids / therapeutic use
Technetium Tc 99m Sestamibi / diagnostic use*
Tomography, Emission-Computed, Single-Photon*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 0/Radiopharmaceuticals; 0/Steroids; 109581-73-9/Technetium Tc 99m Sestamibi; 59-05-2/Methotrexate; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validation of a model to predict all-cause in-hospital mortality in vascular surgical patients.
Next Document:  Ischaemic postconditioning: from bench to bedside ...